We have 2 of 17 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
This review critically examines the convergence of artificial intelligence and advanced oral drug delivery systems as an emerging strategy in schizophrenia management, and highlights a shift toward precision psychiatry, where AI-enabled diagnostics and smart oral therapeutics may support predictive, personalized, and adaptive care in schizophrenia.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
